News
Silgan Holdings Q1 Earnings Surpass Estimates, Shares Rise 4%
Shares of Silgan Holdings Inc. SLGN moved up 4% since reporting record adjusted earnings of 82 cents per share in first-quarter 2025 on Wednesday, beating the Zacks Consensus Estimate of 78 cents
Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
The world’s largest pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), recently had its worst day in a long, long time. On May 1, Lilly reported Q1
Symbiotic Gears Up to Report Q2 Earnings: What's in the Offing?
Symbotic Inc. SYM is scheduled to release second-quarter fiscal 2025 results on May 7, after market close.
The company surpassed the Zacks Consensus Estimate in three of the four trailing quarters
Deckers Stock Looks Overvalued at 18.15X: Time to Consider Selling?
Deckers Outdoor Corporation DECK is trading at a price-to-earnings (P/E) multiple well above the Zacks Retail-Apparel and Shoes industry average. DECK’s forward 12-month P/E ratio sits at 18.15
Freshpet Misses Earnings Estimates in Q1, Lowers 2025 Guidance
Freshpet, Inc. FRPT reported mixed first-quarter 2025 results, wherein the top line surpassed the Zacks Consensus Estimate and increased year over year. However, the bottom line missed the consensus
INSP Stock Gains Following Q1 Earnings Beat, Gross Margin Contracts
Inspire Medical Systems, Inc. INSP delivered an earnings per share (EPS) of 10 cents in first-quarter 2025 against the year-ago period’s loss of 34 cents per share and the Zacks Consensus Estimate
Expeditors Q1 Earnings & Revenues Top Estimates, Improves Y/Y
Expeditors International of Washington’s EXPD first-quarter 2025 earnings of $1.47 per share beat the Zacks Consensus Estimate of $1.30. The bottom line increased 26% year over year, owing to strong
VIstra is Set to Release Q1 Earnings: How to Play the Stock?
Vistra Corp. VST is expected to deliver improvements in its top line and its earnings per share when it reports first-quarter 2025 results on May 7, before market open. (See the Zacks Earnings
Earnings Estimates Rising for Duolingo (DUOL): Will It Gain?
Duolingo, Inc. (DUOL) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with
Earnings Estimates Moving Higher for NB Bancorp, Inc. (NBBK): Time to Buy?
NB Bancorp, Inc. (NBBK) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue
Surging Earnings Estimates Signal Upside for Orchid Island (ORC) Stock
Orchid Island (ORC) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with
Why Red River Bancshares (RRBI) Might be Well Poised for a Surge
Investors might want to bet on Red River Bancshares (RRBI), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price
Should You Buy, Hold or Sell Energy Fuels Stock Ahead of Q1 Earnings?
Energy Fuels Inc. UUUU is anticipated to witness a year-over-year decline in revenues and incur a loss when it announces first-quarter 2025 results on May 8.
The consensus estimate for UUUU’s
Will LPL Financial (LPLA) Beat Estimates Again in Its Next Earnings Report?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering LPL Financial Holdings Inc. (LPLA), which
Can Granite Ridge Resources, Inc. (GRNT) Keep the Earnings Surprise Streak Alive?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Granite Ridge Resources, Inc. (GRNT), which
Why Campbell (CPB) Could Beat Earnings Estimates Again
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Campbell's
Why Canadian Imperial Bank (CM) is Poised to Beat Earnings Estimates Again
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Canadian
Will Lyft (LYFT) Beat Estimates Again in Its Next Earnings Report?
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Lyft (LYFT), which belongs to the Zacks
Will Smucker (SJM) Beat Estimates Again in Its Next Earnings Report?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Smucker (SJM)
Extreme Networks (EXTR) Upgraded to Buy: Here's Why
Investors might want to bet on Extreme Networks (EXTR), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates --
Are You Looking for a Top Momentum Pick? Why Duolingo, Inc. (DUOL) is a Great Choice
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even
LiveRamp (RAMP) Upgraded to Buy: Here's What You Should Know
LiveRamp (RAMP) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates --
What Makes Oddity Tech (ODD) a Strong Momentum Stock: Buy Now?
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even
Ferrari (RACE) Upgraded to Buy: Here's What You Should Know
Ferrari (RACE) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the
What Makes CVS Health (CVS) a New Buy Stock
CVS Health (CVS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates --


